DEF 14AThe Ballot
Aclaris Therapeutics, Inc. files DEF 14A
Filed Apr 25, 2024 · 2y ago · Accession 0001558370-24-005677
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- DEF 14A
- Filing date
- Apr 25, 2024
- Report date
- Jun 6, 2024
- Document
- acrs-20240606xdef14a.htm
- Size
- 3.3 MB